GRB10 and lung carcinoma: Based on the elevated BAE, MAE and TE signatures observed for various cancers over benign lesions, we formulated a statistical malignancy prediction model and identified GNAS, GRB10 and SNRPN as effective diagnostic biomarkers in ten different cancer types, including lung cancer [30].